Translating world-leading medical research innovations into commercial solutions.
QIMR Berghofer is one of Australia’s only fully integrated centres for clinical biomedical research.
Our researchers are world-leaders in the fields of cancer, infectious diseases, mental health and chronic disorders, authoring over 860 peer-review publications annually in leading international journals.
With more than 900 scientists, students and support staff housed across three purpose-built buildings in the Herston health precinct, QIMR Berghofer is one of Australia’s largest and most successful independent medical research institutes.
We have the capability to translate fundamental, basic research from the discovery phase through development, scale-up and manufacture in our Good Manufacturing Practices (GMP) accredited laboratory, Q-Gen Cell Therapeutics. We also conduct Phase I and II clinical trials in our wholly owned, state-of-the-art 62-bed facility, Q-Pharm Pty Ltd.
The QIMR Berghofer Business Development team manages over 160 patent families, offering a wealth of collaborative and commercial opportunities for industry and government.
We have a strong track record of partnering with leading pharmaceutical and biotech companies to further develop early-stage technologies, generating over $21 million in annual commercial revenue in the last financial year. In addition to licensing and partnering outcomes, we facilitate contract research and consulting projects for industry clients.
Our team includes specialists in commercialisation, IP protection, patent law, clinical trial and project management and industry-backed grant opportunities.